Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China

• Main Authors: Wei Zhuang (Author), Zheng Fan (Author), Yanqi Chu (Author), Haizheng Wang (Author), Ying Yang (Author), Li Wu (Author), Nan Sun (Author), Ge Sun (Author), Yuqiao Shen (Author), Xiaolan Lin (Author), Guiming Guo (Author), Shengyan Xi (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BackgroundCoronavirus Disease 2019 (COVID-19) is an emerging and rapidly evolving disease, with no recommended effective anti-coronavirus drug treatment. Traditional Chinese Patent Medicines (CPMs) have, however, been widely used to treat COVID-19 in China, and a number of clinical practice results...